Literature DB >> 15607809

KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation.

Karl-Johan Malmberg1, Marie Schaffer, Olle Ringdén, Mats Remberger, Hans-Gustaf Ljunggren.   

Abstract

KIR-ligand mismatch in the graft-versus-host (GVH) direction between donor and recipient in allogeneic stem cell transplantation (ASCT) may trigger NK cell alloreactivity. Such KIR-ligand mismatch has been associated with improved survival after haploidentical ASCT for acute myeloid leukemia (AML). Its role in unrelated ASCT has been more controversial. In an analysis of 190 unrelated ASCTs for hematological malignancies, we observed that KIR-ligand mismatch was associated with increased transplantation related mortality (TRM) and decreased overall survival. The increased TRM was a consequence of a higher rate of infections. Thus, the presence of alloreactive NK cells can potentially interfere with effective immunity to infections in the early post-transplantation period. Here, we review the discrepancies in published reports on KIR-ligand mismatch in unrelated ASCT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15607809     DOI: 10.1016/j.molimm.2004.07.037

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  21 in total

1.  Mapping of susceptibility and protective loci for acute GVHD in unrelated HLA-matched bone marrow transplantation donors and recipients using 155 microsatellite markers on chromosome 22.

Authors:  Tomoki Kikuchi; Taeko K Naruse; Makoto Onizuka; Suyun Li; Tetsuaki Kimura; Akira Oka; Yasuo Morishima; Jerzy K Kulski; Shingo Ichimiya; Noriyuki Sato; Hidetoshi Inoko
Journal:  Immunogenetics       Date:  2007-01-03       Impact factor: 2.846

2.  NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation.

Authors:  Andreas T Björklund; Marie Schaffer; Cyril Fauriat; Olle Ringdén; Mats Remberger; Christina Hammarstedt; A John Barrett; Per Ljungman; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Blood       Date:  2010-01-22       Impact factor: 22.113

3.  KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation.

Authors:  Sarah Cooley; Valarie McCullar; Rosanna Wangen; Tracy L Bergemann; Stephen Spellman; Daniel J Weisdorf; Jeffrey S Miller
Journal:  Blood       Date:  2005-08-30       Impact factor: 22.113

4.  Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression.

Authors:  Maria R Parkhurst; John P Riley; Mark E Dudley; Steven A Rosenberg
Journal:  Clin Cancer Res       Date:  2011-08-15       Impact factor: 12.531

5.  Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.

Authors:  Jeffery S Miller; Sarah Cooley; Peter Parham; Sherif S Farag; Michael R Verneris; Karina L McQueen; Lisbeth A Guethlein; Elizabeth A Trachtenberg; Michael Haagenson; Mary M Horowitz; John P Klein; Daniel J Weisdorf
Journal:  Blood       Date:  2007-02-22       Impact factor: 22.113

6.  Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer cells after NKG2A and LIR-1 blockade.

Authors:  Robert Godal; Veronika Bachanova; Michelle Gleason; Valarie McCullar; Gong H Yun; Sarah Cooley; Michael R Verneris; Philip B McGlave; Jeffrey S Miller
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-06       Impact factor: 5.742

7.  The diversity of KIR gene in Chinese Northern Han population and the impact of donor KIR and patient HLA genotypes on outcome following HLA-identical sibling allogeneic hematopoietic stem cell transplantation for hematological malignancy in Chinese people.

Authors:  Li Ping Dou; De Hua Zheng; Chang Wang; Jun Hua Liu; Jing Fen Sun; Hai Jie Jin; Chun Ji Gao; Li Yu; Wan Ming Da
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490

8.  Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia.

Authors:  Sarah Cooley; Daniel J Weisdorf; Lisbeth A Guethlein; John P Klein; Tao Wang; Steven G E Marsh; Stephen Spellman; Michael D Haagenson; Koy Saeturn; Martha Ladner; Elizabeth Trachtenberg; Peter Parham; Jeffrey S Miller
Journal:  J Immunol       Date:  2014-04-18       Impact factor: 5.422

9.  Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.

Authors:  Claudio G Brunstein; John E Wagner; Daniel J Weisdorf; Sarah Cooley; Harriet Noreen; Juliet N Barker; Todd DeFor; Michael R Verneris; Bruce R Blazar; Jeffrey S Miller
Journal:  Blood       Date:  2009-03-27       Impact factor: 22.113

Review 10.  Risk assessment in haematopoietic stem cell transplantation: histocompatibility.

Authors:  Effie W Petersdorf
Journal:  Best Pract Res Clin Haematol       Date:  2007-06       Impact factor: 3.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.